Related references
Note: Only part of the references are listed.Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
Somala Mohammed et al.
MOLECULAR THERAPY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition
Miriam Gaggianesi et al.
CANCER RESEARCH (2017)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Avery D. Posey et al.
IMMUNITY (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
Richard Beatson et al.
NATURE IMMUNOLOGY (2016)
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
Fengtao You et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
Dawei Shou et al.
ONCOTARGET (2016)
Fine-tuning the CAR spacer improves T-cell potency
Norihiro Watanabe et al.
ONCOIMMUNOLOGY (2016)
IL4 receptor a mediates enhanced glucose and glutamine metabolism to support breast cancer growth
Katherine T. Venmar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
Katherine Venmar Bankaitis et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad
Lacey Haddon et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
IL4 Receptor ILR4α Regulates Metastatic Colonization by Mammary Tumors through Multiple Signaling Pathways
Katherine T. Venmar et al.
CANCER RESEARCH (2014)
Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor
Ann M. Leen et al.
MOLECULAR THERAPY (2014)
Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells
Usanarat Anurathapan et al.
MOLECULAR THERAPY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Lessons from immunology: IL4R directly promotes mammary tumor metastasis
Katherine T. Venmar et al.
ONCOIMMUNOLOGY (2014)
Optimizing the production of suspension cells using the G-Rex M series
Pradip Bajgain et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Myeloid-derived suppressor cells in breast cancer
Joseph Markowitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
MUC1 and metastatic cancer Expression, function and therapeutic targeting
Teresa M. Horm et al.
CELL ADHESION & MIGRATION (2013)
Regulatory T cells increase in breast cancer and in stage IV breast cancer
Zhi-kuan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Scott Wilkie et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Regulation of innate CD8+ T-cell activation mediated by cytokines
Bailey E. Freeman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta 1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response?
Mahboobeh Razmkhah et al.
CELLULAR IMMUNOLOGY (2011)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor
Yozo Nakazawa et al.
MOLECULAR THERAPY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Regulatory T cells and breast cancer: implications for immunopathogenesis
Maria Angelica Ehara Watanabe et al.
CANCER AND METASTASIS REVIEWS (2010)
Inflammatory cytokines as a third signal for T cell activation
Julie M. Curtsinger et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Over-expression of ST3Gal-I promotes mammary tumorigenesis
Gianfranco Picco et al.
GLYCOBIOLOGY (2010)
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
N. Khodarev et al.
ONCOGENE (2010)
CAR Mechanics: Driving T Cells into the MUC of Cancer
John Maher et al.
CANCER RESEARCH (2009)
Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7
Juan F. Vera et al.
MOLECULAR THERAPY (2009)
Gene expression profiling of the tumor microenvironment during breast cancer progression
Xiao-Jun Ma et al.
BREAST CANCER RESEARCH (2009)
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
M. Todaro et al.
CELL DEATH AND DIFFERENTIATION (2008)
Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor
Scott Wilkie et al.
JOURNAL OF IMMUNOLOGY (2008)
Cytokine comparisons between women with breast cancer and women with a negative breast biopsy
Debra E. Lyon et al.
NURSING RESEARCH (2008)
APC-derived cytokines and T cell polarization in autoimmune inflammation
Ilona Gutcher et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
Gulisa Turashvili et al.
BMC CANCER (2007)
IL-7: maintaining T-cell memory and achieving homeostasis
LM Bradley et al.
TRENDS IN IMMUNOLOGY (2005)
Tissue and serum MUC1 mucin detection in breast cancer patients
MV Croce et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function
JM Curtsinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Signaling from cytokine receptors that affect Th1 responses
AM Hanlon et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
A STAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells
IC Gaemers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
